◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › CME

CME Group Inc (CME) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

FINANCIAL SERVICES · Financial Exchanges & Data · DATA UPDATED 2026-07-13

CME Group Inc (CME) operates in the Financial Exchanges & Data industry and is headquartered in Chicago, United States with about 3,875 employees. Its market capitalization is roughly $92 billion. In the fiscal year ended 2025-12-31, CME reported $6.5B in revenue and $4.0B in net income.

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide.

Interactive charts & full statements → Open the CME valuation workbench →

CME Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Revenue$6.8B$6.5B$6.1B$5.6B$5.0B$4.7B$4.9B$4.9B$4.3B$3.6B$3.6B$3.3B$3.1B$2.9B$2.9B$3.3B$3.0B$2.6B$2.6B$1.8B$1.1B
Gross Profit$5.8B$5.6B$5.3B$4.8B$4.3B$3.9B$4.0B$4.0B$3.6B$3.1B$3.1B$2.7B$2.5B$2.4B$2.4B$2.8B$2.5B$2.1B$2.1B$1.4B$790M
Gross Margin %86.3%86.1%86.1%85.2%85.0%82.2%82.5%81.5%84.4%84.5%84.9%82.5%81.2%81.1%81.6%84.2%84.3%79.7%80.4%79.7%72.5%
Operating Income (EBIT)$4.4B$4.2B$3.9B$3.4B$3.0B$2.6B$2.6B$2.6B$2.6B$2.3B$2.2B$2.0B$1.8B$1.6B$1.7B$2.0B$1.8B$1.6B$1.6B$1.1B$621M
Operating Margin %65.6%64.9%64.1%61.6%60.1%56.4%54.0%53.2%60.5%63.4%61.2%59.8%56.8%55.8%58.1%61.6%61.0%60.8%61.8%59.8%57.0%
Net Income$4.2B$4.0B$3.5B$3.2B$2.7B$2.6B$2.1B$2.1B$2.0B$4.1B$1.5B$1.2B$1.1B$977M$896M$1.8B$951M$826M$715M$659M$407M
Net Margin %62.8%62.0%57.5%57.8%53.6%56.2%43.1%43.5%45.5%111.5%42.7%37.5%36.2%33.3%30.8%55.2%31.7%31.6%27.9%37.5%37.4%
EBITDA$6.0B$5.7B$5.0B$4.7B$4.0B$3.9B$3.4B$3.3B$3.2B$2.9B$2.6B$2.3B$2.1B$2.0B$2.1B$2.3B$2.1B$1.8B$1.6B$1.2B$696M
Earnings Per Share (EPS)$11.75$11.23$9.80$8.97$7.49$7.35$5.87$5.91$5.71$11.94$4.53$3.69$3.35$2.92$2.70$5.43$2.86$2.48$2.43$2.99$2.32
Shares Outstanding (M)363M360M360M360M359M359M359M358M344M340M339M338M336M334M332M334M332M333M295M221M176M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CME Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue$1.9B$1.6B$1.5B$1.7B$1.6B$1.5B$1.6B$1.5B
Gross Profit$1.7B$1.4B$1.3B$1.5B$1.4B$1.3B$1.4B$1.3B
Gross Margin %88.1%85.4%84.5%86.9%87.4%85.5%86.2%86.6%
Operating Income (EBIT)$1.3B$1.0B$973M$1.1B$1.1B$947M$1.0B$1.0B
Operating Margin %69.7%61.8%63.2%66.7%67.5%62.1%64.6%65.3%
Net Income$1.2B$1.2B$908M$1.0B$956M$875M$913M$883M
Net Margin %61.4%70.8%59.1%59.8%58.2%57.3%57.6%57.6%
EBITDA$1.6B$1.6B$1.3B$1.5B$1.4B$1.2B$1.3B$1.3B
Earnings Per Share (EPS)$3.18$3.24$2.52$2.81$2.65$2.43$2.54$2.45
Shares Outstanding (M)363M360M360M360M360M360M360M360M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CME Free Cash Flow History

Cash flowTTM → 2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Cash from Operations (CFO)$4.4B$4.3B$3.7B$3.5B$3.1B$2.4B$2.7B$2.7B$2.4B$1.8B$1.7B$1.5B$1.3B$1.3B$1.2B$1.3B$1.4B$1.1B$1.2B$814M$472M
Capital Expenditures (CapEx)$91M$84M$94M$76M$90M$127M$198M$246M$117M$82M$92M$114M$141M$126M$142M$172M$160M$158M$200M$164M$88M
Free Cash Flow (FCF)$4.3B$4.2B$3.6B$3.4B$3.0B$2.3B$2.5B$2.4B$2.3B$1.8B$1.6B$1.4B$1.2B$1.2B$1.1B$1.2B$1.2B$925M$997M$651M$384M
FCF Margin %64.1%64.3%58.7%60.5%59.1%48.5%51.6%49.9%53.9%48.2%45.2%42.1%37.0%39.3%36.9%35.8%39.8%35.4%38.9%37.1%35.2%
Dividends Paid$4.1B$3.9B$3.6B$3.2B$2.6B$2.2B$2.1B$1.7B$2.1B$2.0B$1.8B$1.3B$1.5B$599M$1.2B$373M$913M$306M$615M$152M$88M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CME Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Cash from Operations (CFO)$1.3B$1.1B$968M$1.1B$1.1B$1.0B$1.0B$777M
Capital Expenditures (CapEx)$22M$32M$18M$18M$14M$26M$30M$18M
Free Cash Flow (FCF)$1.2B$1.1B$950M$1.0B$1.1B$992M$973M$759M
FCF Margin %65.8%66.8%61.8%61.5%67.1%65.0%61.4%49.5%
Dividends Paid$2.7B$455M$455M$455M$2.6B$419M$418M$418M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CME Balance Sheet History

Balance sheet2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Assets$202.0B$198.5B$137.4B$129.7B$174.2B$196.8B$124.7B$75.2B$77.5B$75.8B$69.4B$67.4B$72.2B$54.3B$38.9B$40.8B$35.0B$35.7B$48.2B$20.3B$4.3B
Cash & Cash Equivalents$2.4B$4.4B$2.9B$2.9B$2.7B$2.8B$1.6B$1.6B$1.4B$1.9B$1.9B$1.7B$1.4B$2.5B$1.6B$1.0B$855M$261M$298M$845M$970M
Total Liabilities$175.4B$169.8B$111.0B$103.0B$147.3B$169.4B$98.3B$49.1B$51.5B$53.4B$49.0B$46.8B$51.3B$33.1B$17.4B$19.1B$14.9B$16.4B$29.5B$8.0B$2.8B
Total Debt (Short + Long-Term)$3.4B$3.5B$3.4B$3.5B$3.4B$3.4B$3.5B$3.8B$4.4B$46.4B$39.8B$37.8B$42.7B$2.9B$2.9B$11.4B$2.5B$2.3B$3.2B$164M$521M
Total Shareholders' Equity$26.6B$28.7B$26.5B$26.7B$26.9B$27.4B$26.4B$26.2B$25.9B$22.4B$20.3B$20.6B$20.9B$21.2B$21.4B$21.6B$20.1B$19.3B$18.7B$12.3B$1.5B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CME viewer.

Other Companies in Financial Exchanges & Data

← CMDBAll stocksCMG →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.